Inventor · disambiguated record
Maria Ornella Tinti
Also filed as: TINTI MARIA O · TINTI MARIA ORNELLA
82 granted patents·10 pending applications·438 citations·filing 1979–2010
99Inventor score
Files withSIGMA TAU IND FARMACEUTI81CARMINATI PAOLO2CAVAZZA CLAUDIO1INST NAZ PER LO STUDIO E LA CU1IST NAZ STUD CURA DEI TUMORI1
Top patents by PatentIndex Score
92 records- 0195US6369073B1Compounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Apr 9, 2002·95 cites·21 claims
- 0285US6444701B1Compounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2001·Granted Sep 3, 2002·19 cites·20 claims
- 0380US7498340B2Esters in position 20 of camptothecinsSIGMA TAU IND FARMACEUTI·Filed 2007·Granted Mar 3, 2009·4 cites·6 claims
- 0478US5498633AEsters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activitySIGMA TAU IND FARMACEUTI·Filed 1995·Granted Mar 12, 1996·16 cites·11 claims
- 0577US6797281B1Esters of I-carnitine or alkanoyl I-carnitinesSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Sep 28, 2004·9 cites·26 claims
- 0677US6528684B1Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acidSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Mar 4, 2003·10 cites·6 claims
- 0776US7705012B2Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agentsSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Apr 27, 2010·4 cites·11 claims
- 0873USRE41226ECompounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2006·Granted Apr 13, 2010·1 cites·20 claims
- 0973USRE40861ECompounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2006·Granted Jul 21, 2009·1 cites·21 claims
- 1073US6566552B2Industrial process for the production of L-carnitineSIGMA TAU IND FARMACEUTI·Filed 2001·Granted May 20, 2003·7 cites·11 claims
- 1173US6420599B2Chemical process for the stereoselective synthesis of R-(-)-carnitineSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Jul 16, 2002·7 cites·1 claims
- 1273US5272151AAminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substancesSIGMA TAU IND FARMACEUTI·Filed 1992·Granted Dec 21, 1993·31 cites·10 claims
- 1373US5041643AProcess for the production of R(+)-aminocarnitine and S(-)-aminocarnitineSIGMA TAU IND FARMACEUTI·Filed 1990·Granted Aug 20, 1991·13 cites·4 claims
- 1472US6822115B2Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acidSIGMA TAU IND FARMACEUTI·Filed 2003·Granted Nov 23, 2004·8 cites·15 claims
- 1571US6337349B2Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrateSIGMA TAU IND FARMACEUTI·Filed 1998·Granted Jan 8, 2002·28 cites·11 claims
- 1671US5412113AProcess for manufacturing L-(-)-carnitine from a waste product having opposite configurationSIGMA TAU IND FARMACEUTI·Filed 1993·Granted May 2, 1995·10 cites·7 claims
- 1768US7589099B27-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonistsSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Sep 15, 2009·1 cites·9 claims
- 1867US4551477AEsters of alkoxy-acylderivatives of carnitine and pharmaceutical compositions containing sameSIGMA TAU IND FARMACEUTI·Filed 1984·Granted Nov 5, 1985·7 cites·3 claims
- 1966US7629003B2Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compoundsSIGMA TAU IND FARMACEUTI·Filed 2003·Granted Dec 8, 2009·2 cites·48 claims
- 2066US5491260AProcess for manufacturing L-(-)-carnitine from derivatives having a configuration opposite to that of L-(-)-carnitineSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Feb 13, 1996·9 cites·19 claims
- 2165US7452900B2Esters in position 20 of camptothecinsSIGMA TAU IND FARMACEUTI·Filed 2003·Granted Nov 18, 2008·5 cites·5 claims
- 2264US5155102A1-alkyl-3-(acylamino)-ε-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing sameSIGMA TAU IND FARMACEUTI·Filed 1991·Granted Oct 13, 1992·9 cites·14 claims
- 2363US6887892B2Tricyclic derivatives of indole with antiangiogenic activitySIGMA TAU IND FARMACEUTI·Filed 2001·Granted May 3, 2005·1 cites·8 claims
- 2461US7585519B2Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compoundsSIGMA TAU IND FARMACEUTI·Filed 2007·Granted Sep 8, 2009·0 cites·9 claims
- 2559US6051608ASolid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarateSIGMA TAU IND FARMACEUTI·Filed 1998·Granted Apr 18, 2000·14 cites·11 claims
- 2659US5061725A(pyrrolidin-2-one-1-yl) acetamides and enhancers of learning and memory pharmaceutical compositions comprising sameSIGMA TAU IND FARMACEUTI·Filed 1990·Granted Oct 29, 1991·9 cites·17 claims
- 2757US7799921B2Stereoselective process and crystalline forms of a camptothecinSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Sep 21, 2010·0 cites·22 claims
- 2855US5625085AEsters of acyl L-carnitines and pharmaceutical compositons containing same for treating endotoxic shockSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Apr 29, 1997·4 cites·3 claims
- 2955US5532409AProcess for producing R-aminocarnitine and S-aminocarnitineSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Jul 2, 1996·5 cites·4 claims
- 3055US2004186175A1Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compoundsSIGMA TAU IND FARMACEUTI·Filed 2004·Application pending·0 cites
- 3154US7084166B2Bis-heterocyclic compounds with antitumour and chemosensitising activitySIGMA TAU IND FARMACEUTICHEE R·Filed 2001·Granted Aug 1, 2006·1 cites·2 claims
- 3254US5925369ABis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activityFiled 1997·Granted Jul 20, 1999·15 cites·11 claims
- 3354US4483869AThiocarnitines, process for their preparation and pharmaceutical compositions containing sameSIGMA TAU IND FARMACEUTI·Filed 1981·Granted Nov 20, 1984·3 cites·10 claims
- 3453US5543556AEsters of acyl l-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of comaSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Aug 6, 1996·7 cites·2 claims
- 3552US4593043AMercapto acyl-carnitines and pharmaceutical compositions containing sameSIGMA TAU IND FARMACEUTI·Filed 1982·Granted Jun 3, 1986·4 cites·11 claims
- 3651US8124769B2Stereoselective process and crystalline forms of a camptothecinCARMINATI PAOLO·Filed 2010·Granted Feb 28, 2012·0 cites·21 claims
- 3751US8101758B2Stereoselective process and crystalline forms of a camptothecinCARMINATI PAOLO·Filed 2010·Granted Jan 24, 2012·0 cites·20 claims
- 3851US2008293812A1Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregatesSIGMA TAU IND FARMACEUTI·Filed 2007·Application pending·0 cites
- 3950US4240984AProcess for producing aromatic aldehydesSIGMA TAU IND FARMACEUTI·Filed 1979·Granted Dec 23, 1980·3 cites·10 claims
- 4050US2005124647A1Tricyclic derivatives of indole with antiangiogenic activitySIGMA TAU IND FARMACEUTI·Filed 2005·Application pending·0 cites
- 4149US5599978AProcess for manufacturing L-(-)-carnitine from a waste product having opposite configurationSIGMA TAU IND FARMACEUTI·Filed 1995·Granted Feb 4, 1997·4 cites·6 claims
- 4249US5547986AEster of L-carnitine with gamma-hydroxybutyric acid and pharmaceutical compositions containing it for inhibiting neuronal degeneration and for the treatment of comaSIGMA TAU IND FARMACEUTI·Filed 1995·Granted Aug 20, 1996·7 cites·7 claims
- 4349US5534549AEasters of acyl L-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of comaSIGMA TAU IND FARMACEUTI·Filed 1995·Granted Jul 9, 1996·6 cites·32 claims
- 4449US4806282AProcess for preparing gamma-butyrobetaineSIGMA TAU IND FARMACEUTI·Filed 1987·Granted Feb 21, 1989·3 cites·3 claims
- 4549US4567200AEsters of mercapto acyl-carnitines and pharmaceutical compositions containing sameSIGMA TAU IND FARMACEUTI·Filed 1982·Granted Jan 28, 1986·4 cites·11 claims
- 4648US7858820B2Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chlorideSIGMA TAU IND FARMACEUTI·Filed 2001·Granted Dec 28, 2010·0 cites·2 claims
- 4747US5532410AProcess for manufacturing L(-)-carnitine from a waste product having opposite configurationSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Jul 2, 1996·4 cites·6 claims
- 4847US2006205967A1Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregatesSIGMA TAU IND FARMACEUTI·Filed 2006·Application pending·0 cites
- 4946US7612081B27-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groupsIST NAZ STUD CURA DEI TUMORI·Filed 2004·Granted Nov 3, 2009·0 cites·9 claims
- 5045US6465515B2Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitinesSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Oct 15, 2002·0 cites·9 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Maria Ornella Tinti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →